Latest news - Novo Nordisk
WEBAug 6, 2024 · Latest news. 20 September 2024. Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed. Read more. 19 September 2024. Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function. Read more. 06 …
Company announcements and press releases - Novo Nordisk
WEBEuropean regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events. Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec.
Novo Nordisk to build $4.1 billion North Carolina facility to ...
WEBJun 24, 2024 · Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy,...
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy ...
WEBApr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
Novo’s Tough Month Key in Ending Health Stocks’ Winning ...
WEB5 days ago · European health-care stocks are set to snap their longest winning streak since March 2010, dragged down by concerns over Novo Nordisk A/S’s upcoming third-quarter results and experimental drug ...
Novo Nordisk expects double-digit growth as it boosts Wegovy ...
WEBCOPENHAGEN/LONDON, Jan 31 (Reuters) - Novo Nordisk on Wednesday forecast another year of double-digit growth as the Danish drugmaker began boosting U.S. supplies of its popular weight-loss drug...
Novo valuation surpasses Tesla on experimental obesity drug ...
WEBMar 7, 2024 · Novo Nordisk on Thursday surpassed Tesla Inc in market valuation after the maker of the popular weight-loss drug Wegovy announced positive early trial data for a highly anticipated new obesity...
Novo Nordisk parent to buy Catalent to expand Wegovy supply
WEBNov 21, 2023 · Novo Nordisk's parent company said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost the supply of the highly popular weight loss injection Wegovy and ...
Novo Nordisk trims price for blockbuster obesity drug as ...
WEBMay 3, 2024 · LONDON/COPENHAGEN, May 2 (Reuters) - Novo Nordisk (NOVOb.CO) raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its Wegovy weight-loss treatment, while...
News & media - Novo Nordisk
WEBGet an overview of the Novo Nordisk press releases here or subscribe to our news and get it directly in your mailbox when we have news to tell.